giant cell glioblastoma
Showing 1 - 17 of 17
Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute
Recruiting
- Astrocytoma, Grades II, III and IV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)
Not yet recruiting
- Neoplasms
- +7 more
- Biological G207
-
Birmingham, AlabamaChildren's of Alabama
Jun 1, 2022
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- bevacizumab
- +5 more
-
Los Angeles, California
- +2 more
Feb 10, 2022
Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed
Completed
- Glioblastoma
- +3 more
- Unpulsed DCs
- +6 more
-
Durham, North CarolinaDuke University Medical Center
Jan 3, 2022
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Nov 3, 2021
Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma Trial in Los Angeles (autologous dendritic cells pulsed with tumor
Withdrawn
- Giant Cell Glioblastoma
- +4 more
- autologous dendritic cells pulsed with tumor lysate antigen Vaccine
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020
18F-FEC for Positron Emission Tomography-Computed Tomography
Withdrawn
- Astrocytoma, Grade IV
- +2 more
- External-beam radiation therapy
- Temozolomide
- (no location specified)
Jul 21, 2020
Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)
Completed
- Anaplastic Astrocytoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +5 more
-
Los Angeles, California
- +11 more
Jul 17, 2019
Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)
Terminated
- Anaplastic Astrocytoma
- +8 more
- imetelstat sodium
-
Los Angeles, California
- +10 more
Jun 20, 2018
Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,
Completed
- Glioblastoma
- +4 more
- Rindopepimut (CDX-110) with GM-CSF
- +2 more
-
Birmingham, Alabama
- +222 more
Jan 11, 2018
Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating
Completed
- Teratoid Tumor, Atypical
- +9 more
- azurin-derived cell-penetrating peptide p28
-
Los Angeles, California
- +10 more
Aug 3, 2017
Brain Tumor, Anaplastic Astrocytoma, Anaplastic Ependymoma Trial in Cleveland (ritonavir, lopinavir)
Terminated
- Brain Tumor
- +8 more
-
Cleveland, OhioCleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Apr 24, 2013